As we head into Q4 2020, the new normal in private capital markets has fully set in, generally defined by prudence and caution, albeit a work in progress.
Both public and private companies carrying minority equity stakes at cost under FASB ASC 321 may need to fair value them due to COVID-19.
Developing valuations in a COVID-affected economy means taking new, altered views of a company along with making industry analysis de rigueur.
Business Development Company market participants are focused keenly on valuation in the wake of the novel coronavirus and the impact on their underlying portfolio investments.
Private asset valuations snapped back in Q2 as the economy began to reopen, and private capital investors took concrete steps to shore up portfolio companies.
Valuations are a requirement throughout the IPO process. Management teams are well-advised to seek professional expertise early to avoid missteps and save time, efforts, and cost.
Observations and measures of how COVID-related events through August 31, 2020, have impacted equity market indices, adjustments to EBITDA expectations, and their influence on enterprise values by sector.
The principles developed in valuing common stock options can provide insight into what sports contracts are worth and how they affect risk.
Valuation considerations for rollover equity in PE platform acquisitions.
Now is an ideal time for private company owners to focus on factors that will improve their business value in the event of an opportunity to sell.